Bluesight Announces New System Analytics View in CostCheck, Providing Hospitals with System-Wide Opportunities and Workflows.
Bluesight Announces New System Analytics View in CostCheck, Providing Hospitals with System-Wide Opportunities and Workflows.
Bluesight is excited to introduce System Analytics, a new feature in CostCheck to give hospital…
Case Study: Exploring Savings and Efficiency Gains through Primary and Secondary Wholesalers
According to a study by the ASHP, Non-Federal U.S. Hospitals had a drug spend of…
Statement on GS1 RFID Guidance
“I remember the early days of Kit Check, where my co-founder Tim Kress-Spatz and I…
ControlCheck Benchmarking and User Activity Dashboard now available to all customers
You asked and we listened! The ControlCheck Benchmarking and User Activity Dashboard is now available…
2022 CostCheck Year in Review
2022 CostCheck Year in Review 2022 was a landmark year for CostCheck and our…
Get to know Sandy Still, PharmD, Bluesight’s newest Director of Clinical Strategy
Sandy Still, PharmD, joins Bluesight as the newest Director of Clinical Strategy. Sandy is a…
Bluesight for Controlled Substances announces rebrand to ControlCheck™
It’s with great pleasure that we announce Bluesight for Controlled Substances’ rebrand to ControlCheck. This…
Congressional Legislation Seeks to Ensure “Equitable Treatment” in the 340B Program
Authored by Alan J. Arville, J.D. and Kala K. Shankle, J.D.of Epstein Becker Green In…
Staff Should Know to Report Suspected Diversion
Ensure education for recognizing/reporting suspicious behaviors Reprinted with permission from New Perspectives, Journal of the…
Top 3 Areas Where CostCheck™ Customers Are Seeing the Most Savings.
Top 3 Areas Where CostCheck™ Customers Are Seeing the Most Savings. By Hannah Kanfer BluesightⓇ …